These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2289988

  • 1. A model for the interplay of inflammatory mediators in sepsis--a study in 48 patients.
    Hack CE, Nuijens JH, Strack van Schijndel RJ, Abbink JJ, Eerenberg AJ, Thijs LG.
    Intensive Care Med; 1990; 16 Suppl 3():S187-91. PubMed ID: 2289988
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-8 in sepsis: relation to shock and inflammatory mediators.
    Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA.
    Infect Immun; 1992 Jul; 60(7):2835-42. PubMed ID: 1612748
    [Abstract] [Full Text] [Related]

  • 3. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.
    Dofferhoff AS, de Jong HJ, Bom VJ, van der Meer J, Limburg PC, de Vries-Hospers HG, Marrink J, Mulder PO, Weits J.
    Scand J Infect Dis; 1992 Jul; 24(2):197-204. PubMed ID: 1641597
    [Abstract] [Full Text] [Related]

  • 4. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
    Nuijens JH, Abbink JJ, Wachtfogel YT, Colman RW, Eerenberg AJ, Dors D, Kamp AJ, Strack van Schijndel RJ, Thijs LG, Hack CE.
    J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
    [Abstract] [Full Text] [Related]

  • 5. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
    Gardinali M, Padalino P, Vesconi S, Calcagno A, Ciappellano S, Conciato L, Chiara O, Agostoni A, Nespoli A.
    Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
    [Abstract] [Full Text] [Related]

  • 6. Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.
    Stöve S, Welte T, Wagner TO, Kola A, Klos A, Bautsch W, Köhl J.
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):175-83. PubMed ID: 8991632
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Complement activation during storage of preserved blood].
    Schleunig M, Schmid-Haslbeck M, Wimmer R, Mempel W.
    Beitr Infusionsther; 1990 Mar; 26():81-5. PubMed ID: 1703907
    [Abstract] [Full Text] [Related]

  • 10. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.
    Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J.
    Crit Care Med; 2000 Aug; 28(8):2793-8. PubMed ID: 10966252
    [Abstract] [Full Text] [Related]

  • 11. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
    Carvalho AC, DeMarinis S, Scott CF, Silver LD, Schmaier AH, Colman RW.
    J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
    [Abstract] [Full Text] [Related]

  • 12. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B, Tran TH, Ritz R, Duckert F.
    Am J Clin Pathol; 1984 Oct; 82(4):396-404. PubMed ID: 6206713
    [Abstract] [Full Text] [Related]

  • 13. Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints.
    Abbink JJ, Kamp AM, Nuijens JH, Erenberg AJ, Swaak AJ, Hack CE.
    Ann Rheum Dis; 1992 Oct; 51(10):1123-8. PubMed ID: 1444625
    [Abstract] [Full Text] [Related]

  • 14. Chronological changes in the complement system in sepsis.
    Nakae H, Endo S, Inada K, Yoshida M.
    Surg Today; 1996 Oct; 26(4):225-9. PubMed ID: 8727941
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase.
    Jansen PM, Pixley RA, Brouwer M, de Jong IW, Chang AC, Hack CE, Taylor FB, Colman RW.
    Blood; 1996 Mar 15; 87(6):2337-44. PubMed ID: 8630396
    [Abstract] [Full Text] [Related]

  • 16. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
    Hack CE, Nuijens JH, Felt-Bersma RJ, Schreuder WO, Eerenberg-Belmer AJ, Paardekooper J, Bronsveld W, Thijs LG.
    Am J Med; 1989 Jan 15; 86(1):20-6. PubMed ID: 2783358
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ, Boonstra PW, Rijnsburger AA, Haan J, van Oeveren W.
    Ann Thorac Surg; 1998 May 15; 65(5):1342-7. PubMed ID: 9594864
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.